H. D. Smith recently announced the eight winners of its annual Trading Partners of the Year award, which honors a select group of pharmaceutical and health products manufacturers.
Winners were chosen for their willingness to collaborate actively to grow the industry and advance patient care, said Chris Smith, president and CEO of H. D. Smith.
"Continually building on the foundation of strong relationships with our industry partners is critical to H. D. Smith's success in the market," Smith said. "To honor our trading partners, we present them with awards highlighting how important their partnership is to us."
This year's winners were:
Brand and Specialty Pharmaceuticals: Daiichi-Sankyo, Inc. and Boehringer Ingelheim Pharmaceuticals, Inc.
Generic Pharmaceuticals: Alvogen Inc. and Lupin Pharmaceuticals, Inc.
Health, Beauty and Wellness Products: The Emerson Group and Johnson & Johnson Consumer Products
Home Healthcare Products: Scott Specialties and First Quality
The awards were presented during the 2015 H. D. Smith National Sales & Management Conference, which emphasizes the company's position to partner and innovate within the ever-evolving health care industry to ensure the nation's specialty and retail pharmacies have access to essential products.
The 17th annual meeting epitomizes the lasting relationships that exist between H. D. Smith and its partners.
"Since our founding in 1954, we have been committed to being a strategic ally to our trading partners," Dale Smith, chairman and CEO of H. D. Smith Holding Company, said. "The process of moving essential health care products throughout the supply chain is complex, and critical to our nation's health."
Health care innovation, economics and patient needs demand that our company evolve constantly. Having a strong relationship with our trading partners makes it possible for us to meet that demand and support patient wellness."